Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
HOSPIRA INC (HSP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/29/2012 PRN Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
08/14/2012 PRN Hospira to Present at Upcoming Investor Conferences
08/09/2012 PRN Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin Injection
08/01/2012 PRN Hospira Reports Second-Quarter 2012 Results
06/11/2012 PRN Hospira Introduces Enhanced TheraDoc™ Clinical Surveillance System to Help Hospitals Improve Patient Outcomes and Better Manage Antibiotic Use
03/09/2012 PRN Hospira's TheraDoc™ Clinical Surveillance System to Support Infection Prevention and Patient Safety Efforts at CHRISTUS Health
03/08/2012 PRN Hospira Receives FDA Clearance for Symbiq™ 3.13 Infusion Pump
02/22/2012 PRN Hospira to Present at the Barclays Capital Global Healthcare Conference
02/14/2012 PRN Hospira Reports Fourth-Quarter and Full-Year 2011 Results
01/30/2012 PRN Hospira Names Richard Davies Chief Commercial Officer
01/09/2012 PRN Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
12/22/2011 PRN Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
12/07/2011 PRN Hospira Board Announces Retirement of Executive Chairman and Former CEO Christopher B. Begley; Names John C. Staley Chairman
11/16/2011 PRN Hospira Announces U.S. Launch of Imipenem-Cilastatin for Injection, I.V.
09/06/2011 PRN Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
08/29/2011 PRN Hospira to Host 2011 Investor Day
08/18/2011 PRN Hospira to Present at the Morgan Stanley Global Healthcare Conference
08/17/2011 PRN Hospira Expands Board of Directors
06/27/2011 PRN Hospira to Host Conference Call for Second-Quarter 2011 Results
05/23/2011 PRN DSS and Hospira Win Veterans Affairs Industry Innovation Award for TheraDoc™ Clinical Surveillance System
05/20/2011 PRN Hospira to Present at the Goldman Sachs 32nd Annual Global Healthcare Conference
05/20/2011 PRN Hospira Receives Health Canada Regulatory Approval for Symbiq™ Infusion System Software Upgrade
05/12/2011 PRN Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011
05/10/2011 PRN Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of Shareholders
04/26/2011 PRN Hospira Reports First-Quarter 2011 Results
04/25/2011 PRN Hospira Board Authorizes $1 Billion Share Repurchase Program
04/11/2011 PRN Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011
04/07/2011 PRN Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
04/04/2011 PRN Hospira to Host Conference Call for First-Quarter 2011 Results
04/04/2011 PRN Hospira Submits 510(k) Application to FDA for Symbiq™ Infusion System Modifications
04/01/2011 PRN Hospira Launches Enhanced TheraDoc™ Clinical Surveillance System to Support Patient Safety and Help Improve Care
03/09/2011 PRN Hospira Announces U.S. Approval of Generic Docetaxel
03/07/2011 PRN Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman Role
02/23/2011 PRN Hospira MedNet™ Portal Safety Software Benchmarking System Debuts at HIMSS

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy